secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marpai, Inc. (MRAI)
CIK:        0001844392
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0000950170-23-062900
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marpai Q3 revenue $8.7M (+77% YoY); net loss $7.3M; withdraws S-1, suspends guidance
--------------------------------------------------------------------------------

- Total revenue $8.7M for Q3 2023, up 77% YoY, driven by acquisition of Maestro Health.
- Net loss of $7.3M ($0.98 per share) vs. net loss $5.8M ($1.14 per share) in Q3 2022.
- Customers' employees reached ~37,000, a 126% increase from 16,000 a year ago.
- Withdrew its Form S-1 registration statement due to adverse market conditions; evaluating financing.
- Suspended full-year 2023 financial guidance; company focusing on path to profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844392/000095017023062900/0000950170-23-062900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844392/000095017023062900/mrai-20231113.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-062900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer